{"id":"W3117138907","doi":"10.1017/s0266462320001221","title":"OP544 Appraising Variation In Health Technology Assessment Of Novel Immuno-Oncology Medicines In Australia, Canada, France, And The United Kingdom","year":2020,"lang":"en","type":"article","venue":"International Journal of Technology Assessment in Health Care","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Medicine; Nivolumab; Health technology; Oncology; Family medicine; Cancer; Health care; Internal medicine; Political science; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.311146,0.0004580502,0.001244004,0.01035101,0.004358852,0.007652896,0.002277432,0.001764912,0.001099242],"category_scores_gemma":[0.4195514,0.0007794013,0.001219351,0.01034276,0.005766506,0.00270689,0.007128759,0.001726007,0.00008740176],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.09849775,"about_ca_system_score_gemma":0.1497025,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4814435,"about_ca_topic_score_gemma":0.5096104,"domain_scores_codex":[0.6049138,0.2550058,0.04874649,0.01267079,0.07045911,0.008204034],"domain_scores_gemma":[0.3005909,0.5145407,0.05241415,0.01010417,0.1150225,0.007327619],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"observational","study_design_scores_codex":[0.001782656,0.0002418029,0.2229111,0.0380058,0.001962992,0.001821084,0.3658151,0.0086782,0.005199109,0.02456889,0.01293146,0.3160818],"study_design_scores_gemma":[0.0004100485,0.00158775,0.5732664,0.04833898,0.001670129,0.0007142518,0.162619,0.01063256,0.005661128,0.01021072,0.1841471,0.0007419703],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.843169,0.04805039,0.01477016,0.05161814,0.0003408788,0.008160638,0.002811245,0.0001128039,0.03096682],"genre_scores_gemma":[0.9757794,0.003960839,0.0137298,0.003853407,0.00006117129,0.001407055,0.0004623512,0.00002685466,0.0007191001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5185565,"threshold_uncertainty_score":0.9572824,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.21263117139799,"score_gpt":0.496016894137087,"score_spread":0.283385722739097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}